[go: up one dir, main page]

PT1218749E - Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre - Google Patents

Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre

Info

Publication number
PT1218749E
PT1218749E PT00966291T PT00966291T PT1218749E PT 1218749 E PT1218749 E PT 1218749E PT 00966291 T PT00966291 T PT 00966291T PT 00966291 T PT00966291 T PT 00966291T PT 1218749 E PT1218749 E PT 1218749E
Authority
PT
Portugal
Prior art keywords
psa
igf
prostate cancer
free
detection system
Prior art date
Application number
PT00966291T
Other languages
English (en)
Inventor
Griffiths Keith
Atilla T Turkes
Original Assignee
Joken Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923599.6A external-priority patent/GB9923599D0/en
Priority claimed from GB0012869A external-priority patent/GB0012869D0/en
Application filed by Joken Ltd filed Critical Joken Ltd
Publication of PT1218749E publication Critical patent/PT1218749E/pt

Links

Classifications

    • G01N33/57555—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT00966291T 1999-10-07 2000-10-09 Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre PT1218749E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923599.6A GB9923599D0 (en) 1999-10-07 1999-10-07 Assay
GB0012869A GB0012869D0 (en) 2000-05-27 2000-05-27 Assay

Publications (1)

Publication Number Publication Date
PT1218749E true PT1218749E (pt) 2006-08-31

Family

ID=26244366

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00966291T PT1218749E (pt) 1999-10-07 2000-10-09 Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre

Country Status (8)

Country Link
EP (1) EP1218749B1 (pt)
AT (1) ATE322687T1 (pt)
AU (1) AU781669B2 (pt)
CA (1) CA2388706A1 (pt)
DE (1) DE60027176T2 (pt)
ES (1) ES2259290T3 (pt)
PT (1) PT1218749E (pt)
WO (1) WO2001025790A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2702192A1 (en) 2001-03-14 2002-09-19 Genentech, Inc. Igf antagonist peptides
GB0503741D0 (en) * 2005-02-23 2005-03-30 Eden Research Plc Assay
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
EP2757731B1 (en) 2013-01-21 2015-02-18 Fujitsu Limited MIMO Wireless Communication System
CN106932570A (zh) * 2017-03-07 2017-07-07 中国人民解放军第二军医大学 一种检测前列腺特异性抗原psa的试剂盒及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
WO1999038011A1 (en) * 1998-01-21 1999-07-29 The Brigham And Women's Hospital, Inc. Circulating insulin-like growth factor-i and prostate cancer risk

Also Published As

Publication number Publication date
CA2388706A1 (en) 2001-04-12
EP1218749B1 (en) 2006-04-05
EP1218749A1 (en) 2002-07-03
ATE322687T1 (de) 2006-04-15
AU781669B2 (en) 2005-06-02
ES2259290T3 (es) 2006-10-01
DE60027176T2 (de) 2007-03-08
WO2001025790A1 (en) 2001-04-12
AU7673600A (en) 2001-05-10
DE60027176D1 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
SE0000538D0 (sv) Methods and kits for proximity probing
MY129171A (en) Chromatographic assay device and method for detecting the presence of an analyte in a blood sample
AU2001271501A1 (en) Opposable-element chromatographic assay device for detection of analytes in whole blood samples
EP0853129A3 (en) Devices and methods for detecting nucleic acid analytes in samples
WO2005029073A3 (en) Chromatographic assay device and methods
EP2154522A3 (en) Biosensor
AU4322102A (en) Methods and devices for the quantitative detection of prostate specific membraneantigen and other prostatic markers
WO2001084153A3 (en) Diagnostic device with multiple independent flow paths
BR0116719A (pt) Biossensores tendo aplicação de amostra aperfeiçoada
ATE221076T1 (de) Redox-reversible imidazol-osmiumkomplex-konjugate
EP0915336A3 (en) Opposable-element chromatographic assay device for detection of analytes
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
TR199901569T2 (xx) T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler.
CA2214488A1 (en) Determination of cpsa
WO2002037112A3 (en) Detection of ovarian cancer
EP1183390B8 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
ATE384952T1 (de) Enzymhemmungsimmunverfahren
DE60027045D1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
WO2003100006A3 (en) Method of improved prostate cancer detection
PT1218749E (pt) Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre
WO2002016943A3 (en) Differential immunoassay
JP2002542820A5 (pt)
WO2003089896A3 (en) Rapid assay, method and system for detecting biowarfare agents
AU5352901A (en) Method for quantification of akt protein expression
Diamandis et al. Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma